MediWound MDWD
NASDAQ MDWD
$13.11 -0.48 (-3.53%)
At close: Aug 20, 2026 · 4:00 PM EDT

MediWound (MDWD) Net Margin (2014 - 2026)

MediWound (MDWD) posted quarterly Net Margin of 413.87% for Q4 2025, down 30971.0% year-over-year from N/an in Q4 2024, and down 247.17% quarter-over-quarter from 119.21% in Q3 2025.

MediWound (MDWD) Net Margin (2014 - 2026) Analysis & Trends

MediWound's Net Margin history runs 12 years deep, the most recent figure standing at 413.87% for Q4 2025.

  • In Q4 2025, Net Margin fell 30971.0% year-over-year to 413.87%; the TTM figure through Dec 2025 stood at 215.94% (down 10255.0% YoY), while the FY2025 annual figure was 139.93%, up 919.0% from the prior year.
  • Net Margin for Q4 2025 stood at 413.87%, down from 119.21% in the prior quarter.
  • The five-year high for Net Margin was 26.6% in Q2 2023, with the low at 413.87% in Q4 2025.
  • The 5-year median for Net Margin is 96.97% (2021), against an average of 119.74%.
  • The sharpest annual moves came in 2023 and 2025: Net Margin soared 18310 bps in 2023, then slumped 30971 bps in 2025.
  • MediWound's Net Margin stood at 75.67% in 2021, then grew by 17 bps to 63.07% in 2022, then soared by 49 bps to 31.87% in 2023, then plunged by 227 bps to 104.16% in 2024, then tumbled by 297 bps to 413.87% in 2025.
  • Business Quant data shows MDWD's Net Margin at 413.87% in Q4 2025, 119.21% in Q3 2025, and 341.82% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 30.23%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 31.16%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 12.74%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -3.12%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -16.51%
10 MediWound 169.29 Mn 138.30 Mn 337,000.00 -239.07%

Historic Data

Download Data
DateValue
Jun 30, 2026 -239.97%
Dec 31, 2025 -413.87%
Sep 30, 2025 -119.21%
Jun 30, 2025 -341.82%
Mar 31, 2025 -131.98%
Dec 31, 2024 -104.16%
Sep 30, 2024 -116.19%
Jun 30, 2024 -180.05%
Mar 31, 2024 -74.74%
Dec 31, 2023 -31.87%
Sep 30, 2023 -43.97%
Jun 30, 2023 26.60%
Mar 31, 2023 -96.95%
Dec 31, 2022 -63.07%
Sep 30, 2022 -72.19%
Jun 30, 2022 -156.50%
Mar 31, 2022 -81.26%
Dec 31, 2021 -75.67%
Sep 30, 2021 -101.21%
Mar 31, 2021 -96.97%